Breast cancer survivorship
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference88 articles.
1. National Cancer Institute Division of Cancer Control & Population Scienceshttps://cancercontrol.cancer.gov/ocs/statistics/definitions.html.
2. Centers for Disease Control and Prevention, Heart Diseasehttps://www.cdc.gov/heartdisease/facts.htm.
3. Breast cancer survivorship and cardiovascular disease: emerging approaches in cardio-oncology;Xie;Curr Treat Options Cardiovasc Med,2015
4. Personalized decision making in early stage breast cancer: applying clinical prediction models for anthracycline cardiotoxicity and breast cancer mortality demonstrates substantial heterogeneity of benefit-harm trade off;Upshaw;Clinical Breast Cancer,2019
5. Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative;Breast Cancer Research and Treatment;2024-09-10
2. Optimizing resistance training intensity in supportive care for survivors of breast cancer: velocity-based approach in the row exercise;Supportive Care in Cancer;2024-08-29
3. Implementing Indicators and Trajectories of Return to Work After Breast Cancer Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance Database and Stakeholder Consultation;Clinical Breast Cancer;2024-08
4. Breast Cancer Surgery: A Qualitative Exploration of Concerns Over Time;Journal of Surgical Research;2024-08
5. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial;Progress in Cardiovascular Diseases;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3